10 Important Things to Know About Imbruvica B-Cell Cancer Medication

Imbruvica is a medication used to treat certain types of B-cell cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenstrom's macroglobulinemia. It is an oral medication that works by blocking a protein called Bruton's tyrosine kinase (BTK), which helps cancer cells survive and multiply.

Here are 10 important things to know about Imbruvica:

  1. Imbruvica is FDA-approved for the treatment of several types of B-cell cancers, including CLL, MCL, and Waldenstrom's macroglobulinemia.
  2. It is usually taken once daily, with or without food, and should be swallowed whole with a glass of water.
  3. Common side effects of Imbruvica include diarrhea, fatigue, nausea, bruising, and muscle pain.
  4. Imbruvica can interact with certain medications, so it is important to tell your doctor about all the medications you are taking before starting treatment.
  5. It is important to follow your doctor's instructions carefully when taking Imbruvica, as missing doses or taking too much can affect how well the medication works.
  6. Imbruvica may cause changes in blood cell counts, so your doctor will monitor your blood regularly during treatment.
  7. If you experience any severe or persistent side effects while taking Imbruvica, such as bleeding, infection, or shortness of breath, contact your doctor immediately.
  8. Imbruvica is not recommended for use during pregnancy, as it may harm the unborn baby. Use effective birth control while taking this medication.
  9. It is important to store Imbruvica at room temperature, away from moisture and heat, and to keep it out of the reach of children.
  10. Imbruvica can be a life-saving treatment for many people with B-cell cancers, but it is important to work closely with your healthcare team to manage any side effects and ensure the best possible outcome.